The Role of Genetics in Stroke Risk and Outcome: A Review of Current Evidence
Authors:
Open Access
- 20 October 2025
- journal article
- review article
- Published by Wiley in Brain and Behavior
- Vol. 15 (10) , e70820
Abstract
Purpose: Stroke affects over 15 million people annually, with genetic factors significantly influencing risk and recovery. Understanding the complex interplay of factors contributing to stroke is crucial for developing effective prevention and treatment strategies. Methods: This review aims to synthesize current evidence regarding the genetic underpinnings of both stroke risk and outcome, encompassing ischemic stroke, hemorrhagic stroke, and specific stroke subtypes. Genetic factors uniquely explain variability in stroke risk and treatment response beyond traditional factors like hypertension. We examine the roles of common genetic variants identified through genome‐wide association studies (GWAS), the influence of rare, high‐impact mutations implicated in monogenic stroke disorders, and the contribution of epigenetic modifications to stroke vulnerability and recovery. Furthermore, we explore the impact of genes involved in key pathways such as coagulation, inflammation, lipid metabolism, and cerebrovascular structure and function. Finding: This review highlights the growing body of evidence associating specific genetic variants with increased stroke susceptibility, altered stroke severity, and differential responses to treatment. These findings have the potential to refine risk stratification strategies, identify novel therapeutic targets, and personalize stroke management based on individual genetic profiles. Conclusion: Future research should focus on replicating findings across diverse populations, elucidating gene–environment interactions, and translating genetic discoveries into clinically actionable tools for stroke prevention and improved patient outcomes.Keywords
This publication has 291 references indexed in Scilit:
- ADD1 460W Allele Associated With Cardiovascular Disease in Hypertensive IndividualsHypertension, 2002
- Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE ReviewAmerican Journal of Epidemiology, 2002
- Genetic Variation in CYP2A6-Mediated Nicotine Metabolism Alters Smoking BehaviorTherapeutic Drug Monitoring, 2002
- Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism and Cardiovascular DiseaseDrugs, 2002
- Candidate gene approach for pharmacogenetic studiesPharmacogenomics, 2002
- Association Between the Glu298Asp Polymorphism in the Endothelial Constitutive Nitric Oxide Synthase Gene and Brain InfarctionStroke, 2000
- ACE Gene Polymorphism in Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Prospective Evaluation of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and the Risk of StrokeCirculation, 1999
- Meta-analysis of the ACE gene in ischaemic strokeJournal of Neurology, Neurosurgery & Psychiatry, 1998
- CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.1997